# Anti-bacterial Potential of Nano Calcium Hydroxide as an Intracanal Medication

> **NCT06196515** · PHASE2,PHASE3 · RECRUITING · sponsor: **British University In Egypt** · enrollment: 54 (estimated)

## Conditions studied

- Endodontic Disease
- Pulp Disease, Dental

## Interventions

- **DRUG:** Calcium hydroxide
- **DRUG:** nano calcium hydroxide

## Key facts

- **NCT ID:** NCT06196515
- **Lead sponsor:** British University In Egypt
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-08
- **Primary completion:** 2025-09
- **Final completion:** 2025-12
- **Target enrollment:** 54 (ESTIMATED)
- **Last updated:** 2024-08-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06196515

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06196515, "Anti-bacterial Potential of Nano Calcium Hydroxide as an Intracanal Medication". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06196515. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*